SCHEMBL16235648

SCHEMBL16235648

CS(=O)(=O)c1cnc(N(c2cc(Cl)cc(Cl)c2)S(C)(=O)=O)c(O)n1

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ S100A9 P06702 2/20 0.33
▸ ATF1 P18846 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ PDE4A P27815 1/20 0.31
▸ PDE4B Q07343 1/20 0.31
▸ PDE4C Q08493 1/20 0.31
▸ PDE4D Q08499 1/20 0.31
▸ GLP1R P43220 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16235791 0.83 CCR4 (0.43) GLP1R
SCHEMBL16235463 0.78 S100A9 (0.48) S100A9PDE4APDE4BPDE4CPDE4D
SCHEMBL16235266 0.77 MAPT (0.38) PDE4B
SCHEMBL16235296 0.77 S100A9 (0.31) S100A9
SCHEMBL16235683 0.73 S100A9 (0.40) S100A9
SCHEMBL16235260 0.72 S100A9 (0.37) S100A9
SCHEMBL16235728 0.72 ATF1 (0.39) S100A9ATF1NFKB1
SCHEMBL16235515 0.70 ALDH1A1 (0.30) —
SCHEMBL16235482 0.69 S100A9 (0.55) S100A9
SCHEMBL16235439 0.69 HTT (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925743-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS Active Biotech AB (SE) 2015-10-07 — — EP claimed
WO-2014184234-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2014-11-20 — — WO claimed
EP-2925743-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS Active Biotech AB (SE) 2015-10-07 — — EP disclosed
WO-2014184234-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2014-11-20 — — WO disclosed
Send feedback